Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Harvard Business School
Merck
Baxter
AstraZeneca

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Dexbrompheniramine Maleate And Pseudoephedrine Sulfate, and when can generic versions of Dexbrompheniramine Maleate And Pseudoephedrine Sulfate launch?

Dexbrompheniramine Maleate And Pseudoephedrine Sulfate is a drug marketed by Avanthi Inc and is included in one NDA.

The generic ingredient in DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.

Summary for DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
Drug patent expirations by year for DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE

US Patents and Regulatory Information for DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 078648-001 Feb 27, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Johnson and Johnson
Harvard Business School
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.